definiens: means ( a ) with respect to [COMPANY], the identifica tion of the Licensed Targets, all information and Technology re lated to Target - Binding Antibodies and otherwise in cluded in any Regulatory Filings made, and Regulatory Appr ovals received, by [COMPANY] with respect to License d Products ; and ( b ) with respect to each Party, all i nformation and Technology which is disclosed by or on behalf of such Party ( in such capacity, the ) to the other Party ( in such capacity, the ) hereunder or to any of the Receiving Party ’s empl oyees, consultants, subcontractors or Affiliates, e xcept to the extent that the Receiving Party can demonstr ate by written record or other suitable evidence th at such information, ( i ) as of the date of disclosure is kn own to the Receiving Party or its Affiliates other than by virtue of a prior confidential disclosure by or on behalf of the Disclosing Party to the Receiving Party or i ts Affiliates ; ( ii ) as of the date of disclosure is in, or subsequ ently enters, the public domain through no fault or omission of the Receiving Party or its Affiliates or their resp ective employees, consultants or subcontractors ; ( i ii ) is obtained by the Receiving Party from a Third Party without b reach of any duty and without restriction on disclo sure to or from the Portions of the exhibit, indicated by the mark were omitted and have been filed separately wi th the Securities and Exchange Commission pursuant to the Registrant ’s application requesting confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended